Seizure Tx: AED Flashcards

1
Q

Seizure Introduction

A

Seizures affect approx 40 million people worldwide and 2 million people in the US
1% of the US population is affected
20% - etiology known (brain trauma, tumor, stroke, infection)
80% - etiology unknown
Anti epileptic drugs (AEDs) are #1 treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of partial seizures

A

Partial Seizures: Seizures begin locally

Simple: Without impairment in consciousness
Complex: With impairment in consciousness
Secondary generalized: Partial onset evolving into GTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of generalized seizures

A

Generalized Seizures: Bilaterally symmetrical and w/out local onset

Tonic-clonic: Grand mal
Absence: Petit mal
Myoclonic
Atonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epilepsy syndromes

A

Infantile spasms: Occurs in infants <1yr old, often develop other seizure types later in life

Lennox-gastaut syndrome: Combo of generalized seizure types, cognitive dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Status Epilepticus

A

Continuous seizure activity lasting >30 minutes OR two or more seizures w/out return of consciousness in between

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epilepsy Pathophysiology

A

Sudden electrical disturbance of the cerebral cortex (CNS); Group of neurons fire rapidly and repeatedly for seconds or minutes; Likely related to excess excitatory neurotransmitters, failure of inhibitory neurotransmitters, or combo (imbalance between excitatory and inhibitory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Goals of therapy

A

Control or reduce the frequency of seizures
Ensure adherence
Optimize quality of life
Balance between seizure control and side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

General Treatment Approach

A
  • Determine risk of subsequent seizure: Risk factors include structural CNS lesion, abnormal EEG, partial seizure type, positive family history, and postictal motor paralysis
  • AED selection determined by seizure type, adverse effect profile and patient preference
  • Begin w/monotherapy: 550-70% can be maintained on one AED
  • Titrate dose as needed, depending on seizure control, AE
  • Adherence is KEY: up to 60% of pts w/epilepsy are nonadherent–>treatment failure (AE, don’t have seizures all the time; adolescents have the highest non-adherence)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Non-pharmacologic Therapy

A
  1. Surgery
    - Temporal lobectomy
    - Corpus Collosum section
    - Hemispherctomy
  2. Vagal nerve stimulator implantation: Regular pulses of electrical energy to prevent or interrupt electrical disturbances; Thin, round pulse generator implanted under the skin on the upper left side of the chest; Electrodes connect to the left vagus nerve on the left side of the neck; Costly ($15,000) but has “medication sparing” effect; Can cause hoarseness and cough
  3. Ketogenic Diet: High fat, no carbs; Induces state of ketosis which decreases seizures
  4. Modified Atkins Diet for kids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AEDs Mechanism of Action

A

Effect sodium and calcium channels –>stabilization of neuronal membranes
Enhance inhibitory neurotransmission (GABA)
Decrease excitatory neurotransmission (Glutamate and Aspartate)
–>Increase seizure threshold
–>Inhibition of the spread of abnormal (seizure) discharges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Therapeutic Range

A

Serum concentration that controls seizures w/out causing concentration-related AE
Population data used to determine range
Personal therapeutic range for each patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Concentration-Related AE

A

Most common
Increased drug levels results in increased side effects
Not permanent
See at “peak” concentration or throughout day
Management:
-Lower dose/level
-Change schedule or formulation of medication: take more often at lower dose or take ER form
-D/C med

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Idiosyncratic AE

A
More rare
Not related to dose/level
May be permanent
Seen throughout day
Management: 
-D/C med
-Treat adverse reaction as needed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of AE

A

Concentration-Related

Idiosyncratic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AEDs and Suicide Risk

A
  • Patients taking AEDs seem to have TWICE the risk of suicidal thoughts and behaviors as those not taking the drugs
  • Reason for increased risk is unknown
  • Relative risk appears higher in patients treated for seizure disorders compared to migraines, BDP, or other conditions
  • Patients w/epilepsy already have a higher risk of depression and a THREE-fold higher risk of suicide
  • Risk is small, but patients should be educated to seek help if suicidal thoughts or behavior occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug Interactions: Absorption

A
  • Aluminum or magnesium containing antacids may decrease AED absorption
  • Separate doses by 2 hours or more to prevent interaction
17
Q

Drug Interactions: Distribution

A

Protein Binding

  • Highly protein bound drugs compete for protein binding sites
  • Transient elevation in free drug
  • Ex: Phenytoin and Valproic Acid
18
Q

Drug Interactions: Metabolic

A

CYP450 Enzyme System

  • Substrates
  • Inducers: Increase original med dose
  • Inhibitors: Decrease original med dose
19
Q

AED Cost

A

The newer the med, the more expensive it is

20
Q

AED Dosing

A
Phenytoin (Dilantin): 300-400mg
Carbamazepine (Tegretol): 800-1600mg
Valproic Acid (Depakote): 1000-3000mg
Gabapentin (Neurontin): 1800-3600mg
Lamotrigine (Lamictal): 100-500mg
  • Total daily doses
  • *If a patient uses a generic, keep them on the same generic; don’t change
21
Q

AED Monitoring

A

Monitor therapeutic range: Check once steady state has been reached; MC to measure in the morning at the trough level

  • On inducer: Reach steady state faster
  • On inhibitor: Reach steady state slower
22
Q

Evaluation of Therapy

A
  • Individual therapeutic range should be established
  • Ongoing monitoring of seizure control, adverse effects, drug interactions, adherence, toxicity, and social adjustment
  • Record severity and frequency of seizures in a seizure diary
23
Q

AED use in women of childbearing age

A

Interactions w/contraceptions:
-Enzyme inducers (PHT, CBZ, PB, PRM) -> decreased estrogen concentrations
-Either use higher dose OC or alt method of birth control
Teratogenic effects during pregnancy
-Fetal risk 2-4% w/out epilepsy, 4-6% w/epilepsy and 1 AED
-Goal: monotherapy w/lowest possible dose to control seizures
-Avoid VPA if possible
-Check levels throughout pregnancy
Breastfeeding
-Varies, most are safe

24
Q

Genetic testing recommendations

A
  • Patients of Asian decent should be screened for the HLA-B*1502 gene before starting CBZ and PHT
  • About 5% of pts who have it will develop Stevens-Johnson syndrome or TEN w/CBZ; FDA is working to evaluate the risk w/PHT
  • Certain HLA subtypes will see a drug as harmful and mount an immune response that manifests as a hypersensitivity reaction
25
Q

Epilepsy Treatment Algorithm

A

See Handout for Algorithm

26
Q

Discontinuation of AEDs

A

All of the following criteria must be met before considering D/C:

  • Seizure free for 2-5 yrs
  • Normal neurologic exam
  • Normal IQ
  • Single type of partial or generalized seizure
  • Normal EEG w/treatment

Slowly decrease polytherapy to monotherapy
W/monotherapy, slowly decrease AED over at least 1-3 months to prevent withdrawal seizures
Decrease dose by no more than 1/3 each time

27
Q

SUMMARY

A
  • Seizures affect 1% of the US population
  • The primary treatment for seizure disorders is AED therapy
  • Pharmacologic therapy is based on seizure type
  • Therapy requires ongoing monitoring of seizure control, adverse effects, drug interactions, adherence, toxicity and social adjustment